TIME100 Health Honorees Toast to Progress, Affirmation Over Fear, and Changing a ‘Heartbreaking Reality'
The latest annual TIME100 Health list, which debuted in 2024, highlights scientists, doctors, advocates, educators, and other changemakers working to navigate a year unlike any other in global health, punctuated by conflict and upheavals, while gazing into an uncertain future.
TIME CEO Jessica Sibley kicked off dinner by announcing the launch of a new coverage initiative, TIME Longevity, which aims to capture the people, institutions, and innovations redefining what it means to live longer and age healthier. TIME senior correspondent Alice Park then led a panel discussion on the next era of cancer treatment and diagnosis.
As the dinner wrapped up, four TIME100 Health honorees gave toasts about fighting to restore respect for science, making innovations in public health accessible to those who most need it, supporting the mental wellness of LGBTQ+ youths, and turning a personal near tragedy into nationwide impact.
Ensuring scientific progress doesn't stop
Bill Nye, advocate, science educator, and TV host, donned a signature bow tie as he took the stage. Over the past year in particular he's been using his celebrity to bring awareness to the importance of supporting scientific research and to urge citizens to speak out to lawmakers about the disruptive reductions made by the Trump Administration at vital agencies like the National Oceanic and Atmospheric Administration, the National Institutes of Health, and NASA.
But, 'strangely enough, this would be the time you'd want to be born,' he says. 'More people around the world are better off now than ever before in human history.'
That is thanks to the body of knowledge accrued by science over the course of this history, through studies in evolution, genetics, and DNA. This arc of discovery led to recent medical breakthroughs that have unlocked the potential to free families from genetic ailments that have plagued them for generations. For Nye's family, that includes a neurological disorder called Spino Cerebellar Ataxia. 'We are living at this extraordinary time with genetic research, and this is of great interest to me and my family,' he says.
'What a remarkable time in health care, where we are all able to understand these genes and do something about it,' he continues. 'Meanwhile, funding is being cut. Support of health care or scientific research in health care is being cut. But this will not last. We are going to work together.'
Harkening back to evolutionary biologists Darwin and Wallace who concluded that all living things share a common ancestor, Nye says: 'My friends, all of us, we are more alike than we are different. … So let's work together and make the world better for everyone.'
Finding remedies for malnutrition and its indignity
Dr. Tahmeed Ahmed, executive director of ICDDR Bangladesh, spoke about how treating malnutrition improves human dignity for more than 200 million women and children worldwide. For the last 40 years, he's been working to improve and simplify the treatment for malnutrition. Research has gradually revealed that malnutrition is not only caused by lack of food but also by intestine-damaging bacteria introduced through poor hygiene that can result in poor nutrient absorption. Based on these findings, Ahmed and Dr. Jeffrey Gordon from the Washington University at St. Louis developed a treatment that incorporates beneficial gut bugs that could be easily dispensed into food products by local producers.
'We now know more about what causes malnutrition … we also have a number of remedies,' he says. 'The problem is, how do we take these remedies to the people who need it most, be it in Africa, in South Asia.'
Promoting affirmation over fear
Ronita Nath, vice president of research at the Trevor Project, first shined the spotlight on her fellow honorees in the room. 'Your breakthroughs are redefining what's possible in health and humanity, and it's a privilege to stand alongside you this evening,' she says. Nath then toasted 'every LGBTQ+ young person daring to live authentically in a world that too often misunderstands them' and shared her own experience raising a transgender child.
'Watching him blossom has been a masterclass in what happens when affirmation outruns fear,' Nath says. 'Our research at the Trevor Project shows that when even one adult—whether a parent, teacher, or doctor—affirms a transgender young person's identity, their odds of attempting suicide drop by roughly 45%. In our house, that statistic has a face, a mischievous smile, and an ever‑expanding Lego collection.'
She ended her toast commending the coalition of supportive parents, researchers, crisis counselors, who chose to be brave, dedicated, understanding, and empathetic.
Changing a 'heartbreaking reality'
Damar Hamlin, NFL player and philanthropist, tells the crowd that 'if you had told me just a couple of years ago that I'd be giving a toast at the TIME100 Health Impact Dinner … I probably would've told you you were crazy.' But life doesn't always go as planned, he acknowledges. His sudden cardiac arrest on the field in 2023 and the journey that followed have made him realize that his mission is bigger than football.
'The work I've done in the heart health space … it carries a much deeper weight,' he says 'Sudden cardiac arrest is still the leading cause of death in sports. That's a heartbreaking reality—one that I now live with every day. And because of that, I've found my new life mission: to make sure every kid chasing their dreams can do it safely.'
For the past two years, he's been raising awareness about the importance of CPR and heart health education, pushing to make AEDs more accessible, and working with partners like HeartMates and the American Heart Association.
'Before I close, I want to leave you with something that's been on my heart: Fear has energy. It can hold you back—or it can push you forward. It's not about avoiding fear, but facing it and choosing to grow through it. The biggest part of my comeback wasn't physical—it was about belief. I knew I could do it,' Hamlin says. 'So tonight, I raise this toast to the fighters, the dreamers, and the believers; to those who face fear, do the work, and show up with purpose. Here's to all the impact we make together.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
5 hours ago
- Wall Street Journal
Trump Administration Blocks Funding for CDC Health Programs
WASHINGTON—The Trump administration is blocking funding for a swath of public-health programs run by the Centers for Disease Control and Prevention, the latest flashpoint in a push by the White House to withhold money already approved by Congress. The White House Office of Management and Budget issued the directions in a footnote on an appropriations memo this past week, according to people familiar with the matter. A range of programs won't be fully funded under the freeze.
CNN
7 hours ago
- CNN
UCLA loses federal research funding in administration's ongoing fight with top universities
UCLA is the latest major institution of higher learning to see promised research funding snatched away by the Trump administration, the university's leader said in an open letter to students and faculty Thursday. 'This is not only a loss to the researchers who rely on critical grants,' wrote Chancellor Julio Frenk. 'It is a loss for Americans across the nation whose work, health, and future depend on the groundbreaking work we do.' Grants from the National Science Foundation and the National Institutes of Health are included in the suspensions, Frenk said, but did not provide an amount of how much funding is in peril. The Los Angeles Times reported that roughly $200 million in grants awarded to UCLA are being suspended, citing a partial list of suspended grants provided to them by a source. A spokesperson for the National Science Foundation declined to provide specific figures, saying grant awards are being suspended 'because they are not in alignment with current NSF priorities and/or programmatic goals.' 'We will not fund institutions that promote antisemitism,' said a spokesperson for the Department of Health and Human Services, which includes the National Institutes of Health. 'We will use every tool we have to ensure institutions follow the law.' The Trump administration has repeatedly cited antisemitism – especially in the context of contentious pro-Gaza protests on campuses – as a reason to deny promised funds to universities, including Harvard and Columbia. Harvard is fighting the funding decisions in court, while Columbia agreed to a settlement with the government that restored its grants. The funding cut comes days after the Justice Department's Civil Rights Division announced it found UCLA in violation of federal law by 'acting with deliberate indifference in creating a hostile educational environment for Jewish and Israeli students.' While the formal notice to UCLA said the federal government 'now seeks to enter into a voluntary resolution agreement,' Attorney General Pam Bondi sounded less conciliatory. 'DOJ will force UCLA to pay a heavy price for putting Jewish Americans at risk and continue our ongoing investigations into other campuses in the UC system,' Bondi said in a statement. It is not just the Trump administration that has tangled with UCLA over charges of antisemitism. A group of Jewish students filed suit against the university last June, saying the school allowed discrimination against Jews to flourish following Israel's military operation in Gaza in response to the October 7 attacks. The lawsuit said UCLA leaders waited days before responding to a group of pro-Palestinian protesters that refused to allow students to enter campus unless they agreed to 'a statement pledging their allegiance to the activists' views.' UCLA settled the lawsuit earlier this week for $6.45 million, with more than $2 million of the total going to designated 'organizations that combat antisemitism and support the UCLA Jewish community.' UCLA also agreed it is prohibited from 'knowingly allowing or facilitating the exclusion of Jewish students, faculty, and/or staff' from university programs and activities.
Gizmodo
8 hours ago
- Gizmodo
Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs
The federal government may not have closed the window on paying for GLP-1 weight loss drugs like Ozempic and Zepbound after all. The Trump administration is reportedly planning to conduct an experiment that will allow some people to have obesity drugs covered by their Medicaid and Medicare plans. The Washington Post first broke the news Friday morning, having reportedly obtained documents from the Centers for Medicare and Medicaid Services outlining the plan. It would enable state Medicaid programs and Medicare Part D insurance plans to cover people's medications explicitly meant for 'weight management,' starting next year. Should the experiment go well, it could pave the way to widespread Medicare and Medicaid coverage of these expensive but effective drugs. A Staggering Number of U.S. Adults Are Eligible for Ozempic, Study Finds As things stand now, Medicare cannot directly cover any medications for treating obesity, including newer GLP-1 agents like semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). Programs do have some leeway in providing coverage to people taking Ozempic and similar drugs for diabetes or certain obesity-related conditions, such as heart disease. Last year, the Biden administration proposed a rule designed to end this restriction, opening up coverage to some 7 million Americans on Medicare and Medicaid by 2026. In April this year, though, the Trump administration dropped the proposed rule entirely. However, Health Secretary Robert F. Kennedy Jr., who's previously criticized Ozempic in the past, did state at the time that the White House was still considering a 'framework' to expand coverage. Trump Is Promising to Lower Drug Prices. Don't Count on It According to the Washington Post, the Center for Medicare and Medicaid Innovation—an organization tasked with finding ways to lower health care costs and improve patient care—will be in charge of the experiment. Some specifics of the plan, including the exact criteria for eligibility, may still be up in the air, since the government could provide a window for public comment and further modification if it so chooses. As currently outlined, though, the experiment is expected to run for at least five years. Medicaid programs would reportedly be able to offer coverage starting in April 2026, while Medicare plans could do so in January 2027. The newest GLP-1 drugs like semaglutide have proven to be much more effective at helping people lose weight than diet and exercise alone. But their high costs and limited insurance coverage have impeded many people from obtaining or staying on these treatments long-term (some users are also unable to tolerate the common gastrointestinal side effects they cause). That said, this proposed plan is the latest sign that these cost issues are improving. The list prices of Ozempic and similar drugs have started to drop as of late; for instance, America's upstairs neighbor Canada is expected to approve the first generics of Ozempic early next year (that probably won't happen until 2030 in the U.S., though). The likely arrival of new approved competitors to these drugs as early as next year is also expected to drive down prices in general.
